Asia equities rally on vaccines and Australian GDP
Equity markets are experiencing a wax on, wax off the week, tail-chasing short-term momentum of whichever story carries the most weight on the day. Yesterday it was bubbles, which saw equity markets unwind part of the impressive rallies seen on Monday. The S&P 500 fell 0.81%, the Nasdaq plunged 1.60%, and the Dow Jones eased by 0.46%.
US vaccine manufacturing progress and an impressive Australian GDP print which was higher than expected has lifted animal spirits today, though. US index futures have recovered in Asian trading, with the S&P and Dow futures rising 0.35%, and the Nasdaq futures rising 0.55%.
That has greenlighted Asia to follow suit, and regional equity markets are performing strongly. The Nikkei 225 has risen 0.25%, a muted performance ahead of a government decision on extending Covid-19 restrictions. The Kospi, though, has risen 0.70%, and China’s markets are also rallying strongly. The Shanghai Composite has jumped 1.50%, the CSI 300 by 1.25%, and the Hang Seng has rallied 1.50% higher.
Regionally, Singapore is 0.55% higher, along with Taiwan. Kuala Lumpur and Jakarta are around 0.30% higher, and Australia’s ASX 200 and All Ordinaries are 0.75% and 0.65% higher, respectively.
Assuming no headline surprises, notably bubble ones from important people, hit the wires again today, Europe should follow Asia higher. Wall Street will be a harder one to call. US ADP Employment and ISM data should outperform tonight and Nonfarm Payrolls will be released later in the week. All are likely to surprise to the upside. Depending on Wall Street’s mood, it will be received as a recovery boost, so buy everything. Or, it will be inflationary; we are all doomed, so sell everything. I shall decline to predict Wall Street’s mindset; it has the same inherent dangers as assuming what Mrs Halley is thinking about, or so I have been told regularly. Either way. I end up scolded.